Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Bluebird bio is a biotechnology business based in the US. Bluebird bio stocks (BLUE.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $30.43 – a decrease of 3.78% over the previous week. Bluebird bio employs 323 staff and has a trailing 12-month revenue of around $4 million.
Promoted
National Bank Direct Brokerage
Finder Award
Interactive Brokers
| Latest market close | $3.56 |
|---|---|
| 52-week range | $2.78 - $8.58 |
| 50-day moving average | $3.81 |
| 200-day moving average | $5.85 |
| Wall St. target price | $6.90 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-1.47 |
Note: The dollar amounts in the table below are in Canadian dollars.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the close of $3.56 from 2023-05-26
| 1 week (2023-05-23) | -3.78% |
|---|---|
| 1 month (2023-04-28) | -18.16% |
| 3 months (2023-03-02) | -28.08% |
| 6 months (2022-11-30) | -54.30% |
| 1 year (2022-05-26) | N/A |
|---|---|
| 2 years (2021-05-28) | -88.56% |
| 3 years (2020-05-29) | 63.63 |
| 5 years (2018-05-30) | 182.8 |
Valuing Bluebird bio stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Bluebird bio's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
| Revenue TTM | $4 million |
|---|---|
| Gross profit TTM | $-247,244,000 |
| Return on assets TTM | -16.19% |
| Return on equity TTM | -39.87% |
| Profit margin | 0% |
| Book value | $3.34 |
| Market capitalisation | $378.8 million |
TTM: trailing 12 months
We're not expecting Bluebird bio to pay a dividend over the next 12 months.
Bluebird bio's shares were split on a 1544:1000 basis on 5 November 2021. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 1544 shares. This wouldn't directly have changed the overall worth of your Bluebird bio shares – just the quantity. However, indirectly, the new 35.2% lower share price could have impacted the market appetite for Bluebird bio shares which in turn could have impacted Bluebird bio's share price.
Over the last 12 months, Bluebird bio's shares have ranged in value from as little as $2.78 up to $8.58. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Bluebird bio's is 0.9296. This would suggest that Bluebird bio's shares are less volatile than average (for this exchange).
bluebird bio, Inc. , a biotechnology company, researches, develops, and commercializes gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include ZYNTEGLO (betibeglogene autotemcel) for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell disease (SCD); and SKYSONA (elivaldogene autotemcel) to treat cerebral adrenoleukodystrophy. The company's clinical development programs include HGB-205, HGB-206, and HGB-210 to evaluate the safety and efficacy of lovo-cel in the treatment of patients with SCD; and HGB-204, HGB-205, HGB-207, and HGB-212 to evaluate the safety and efficacy of beti-cel in the treatment of patients with ß-thalassemia. It has license agreement with Orchard Therapeutics Limited. The company was formerly known as Genetix Pharmaceuticals, Inc. , and changed its name to bluebird bio, Inc.
Your guide to how ETFs work and whether this type of investment is right for you.
Read more…
The best stock trading app for beginners is easy to use and offers free trades.
Read more…
Learning how to read stock charts and recognize chart patterns can unlock your success as a trader.
Read more…We show you the best prepaid credit cards in Canada, whether you’re looking for a prepaid card with no fees, cash back rewards, or travel perks, or more.
This guide provides step-by-step instructions on how to buy Sui, lists some exchanges where you can get it and provides daily price data on (SUI).
Compare apps like Nyble in Canada to access emergency funding.
Your guide to buying and financing a car in Canada with RightRide.
Your guide to bad credit car loans in BC and how to find the right financing for your needs.
Compare six ways to finance a camera in Canada, including options for good and bad credit.
This guide provides step-by-step instructions on how to buy Pepe, lists some exchanges where you can get it and provides daily price data on (PEPE).
Compare lenders to find the best personal loan in Saskatchewan for your needs.
Compare interest rates and eligibility requirements of bad credit loans in Winnipeg.
Teaching teenagers how to budget can be a tricky task. 7 experts give their best tips on how to budget for teenagers.
